
Hansa Biopharma’s imlifidase advances to Phase III testing
According to Lund-based Hansa Biopharma AB the study protocol has been greenlighted both by the FDA and the European Medicines Agency (EMA), so its...

Novo Holdings co-leads €40m Qure.ai financing
Qure.ai said it will use the proceeds from the $40m financing round to intesify product development for critical care and community...

Four new autoantigens trigger multiple sclerosis
Despite considerable progress in the treatment of multiplesclerosis (MS), the disease still often leads to permanent neurological disability....

Transine Therapeutics Ltd closes £13.7m seed financing
Transine Therapeutics stressed it will use the proceeds to accelerate its preclinical pipeline of novel therapeutic RNAs (SINEUPs) capable of...

Unilever launches $120m venture with Genomatica
US biotechnology company Genomatica is a producer of sustainable materials derived from plant- or waste-based feedstocks instead of fossil fuels....

EU starts consultation on novel plant breeding methods
he EU Commission has launched its final consultation on the deregulation of new breeding techniques in agriculture. A study commissioned by the...

Argenx SE to raise €637m
Last December, the Breda-based drugmaker got the green lightfrom the US FDA for its injectible anti-acetylcholin receptor antibody fragment...